Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€85.57
14.12.21
€124.00
14.12.22
5.18%
15.12.22

Could be worthwhile Investment >10% per year
buy
Arkema S.A.

Start price
Target price
Perf. (%)
€118.15
13.12.21
€125.00
13.12.22
-26.79%
14.12.22

Could be worthwhile Investment >10% per year
buy
Balyo

Start price
Target price
Perf. (%)
€1.06
13.12.21
€1.40
13.12.22
-62.95%
14.12.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Faurecia S.A.

Start price
Target price
Perf. (%)
€39.97
11.12.21
€43.00
11.12.22
-64.71%
12.12.22

Could be worthwhile Investment >10% per year
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€8.61
08.12.21
€10.00
08.12.22
65.85%
09.12.22

Could be worthwhile Investment >10% per year
buy
Pierre & Vacances S.A.

Start price
Target price
Perf. (%)
€6.78
07.12.21
€10.00
07.12.22
4.13%
22.01.22

Could be worthwhile Investment >10% per year
buy
Orapi

Start price
Target price
Perf. (%)
€6.34
06.12.21
€7.00
06.12.22
-22.48%
07.12.22

Could be worthwhile Investment >10% per year
buy
Hybrigenics S.A.

Start price
Target price
Perf. (%)
€0.12
03.12.21
€0.25
03.12.22
-46.60%
04.12.22

Could be worthwhile Investment >10% per year
buy
Theradiag S.A.

Start price
Target price
Perf. (%)
€2.16
02.12.21
€2.80
02.12.22
4.86%
03.12.22

Could be worthwhile Investment >10% per year
buy
Prodways Group

Start price
Target price
Perf. (%)
€2.92
01.12.21
€3.20
01.12.22
35.27%
02.12.22

Could be worthwhile Investment >10% per year
buy
Accor S.A. Inh.

Start price
Target price
Perf. (%)
€26.64
01.12.21
€33.00
01.12.22
-4.69%
02.12.22

Could be worthwhile Investment >10% per year
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€25.50
01.12.21
€28.00
01.12.22
-31.92%
20.05.22

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
buy
Bouygues S.A.

Start price
Target price
Perf. (%)
€29.98
30.11.21
€34.00
30.11.22
-0.97%
01.12.22

Could be worthwhile Investment >10% per year
buy
Focus Home Interactive SAS

Start price
Target price
Perf. (%)
€38.95
30.11.21
€50.00
30.11.22
18.49%
01.12.22

Could be worthwhile Investment >10% per year
buy
ADL Partner S.A.

Start price
Target price
Perf. (%)
€20.00
30.11.21
-
30.11.22
10.00%
10.12.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€27.10
30.11.21
€36.00
30.11.22
-34.61%
08.01.22

buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.48
30.11.21
-
30.11.22
-50.67%
10.08.22

Could be worthwhile Investment >10% per year
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.48
30.11.21
-
30.11.22
-74.99%
01.12.22

buy
Accor S.A. Inh.

Start price
Target price
Perf. (%)
€26.07
30.11.21
-
30.11.22
-3.30%
01.12.22

Cellectis Nom.

Start price
Target price
Perf. (%)
€7.61
30.11.21
-
30.11.22
1.58%
12.12.21

buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.44
30.11.21
-
30.11.22
-3.29%
12.12.21

buy
Quantum Genomics S.A.

Start price
Target price
Perf. (%)
€4.21
30.11.21
-
30.11.22
0.48%
12.12.21

buy
Valneva SE

Start price
Target price
Perf. (%)
€29.96
30.11.21
€35.00
30.11.22
-66.46%
12.08.22

Could be very worthwhile Investment >20% year